Is a Drug Alone Sufficient to Cause the Drug Hypersensitivity Syndrome?

Archives of Dermatology

Volumn 140, Issue 2, 2004, Pages 226-230

  Wong, Gavin A E ^a   Shear, Neil H ^b  

^a S/Women's Coll Hlth Sci Ctr ^*

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; ETHOSUXIMIDE; IBUPROFEN; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; SULFADIAZINE; VALPROIC ACID; ANTICONVULSIVE AGENT; IMMUNOGLOBULIN; VIRUS ANTIBODY;

BLISTER; DIARRHEA; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EDITORIAL; ENCEPHALITIS; EOSINOPHILIA; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; FACE EDEMA; FEVER; HEPATITIS; HEPATOMEGALY; HERPES SIMPLEX VIRUS; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN A DEFICIENCY; KIDNEY DISEASE; LEUKOCYTOSIS; LIVER DYSFUNCTION; LYMPHADENOPATHY; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; PATHOPHYSIOLOGY; PHARYNGITIS; PRIORITY JOURNAL; PURPURA; RASH; SORE THROAT; THROMBOCYTOPENIA; VIRUS REACTIVATION; VOMITING; BLOOD; HUMAN HERPESVIRUS 6; IMMUNOLOGY; NOTE; PHYSIOLOGY; SYNDROME; VIROLOGY; VIRUS ACTIVATION;

ANTIBODIES, VIRAL; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOGLOBULINS; SYNDROME; VIRUS ACTIVATION;

EID: 1442303074     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.2.226     Document Type: Editorial

References (64)

1. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol. 2001;137:357-364.
2. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250-257.
3. Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol. 1998;11:969-987.
4. Uetrecht JP. New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. Chem. Res Toxicol. 1999;12:387-395.
5. Pichler WJ. Modes of presentation of chemical neoantigens to the immune system. Toxicology. 2002;181-182:49-54.
6. Pullen H, Wright N, Murdoch JMC. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet. 1967;2:1176-1178.
7. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-1674.
8. Descamps V, Bouscarat F, Laglenne S, et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol. 1997;137:605-608.
9. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol. 1998;134:1108-1112.
10. Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol. 1998;134:1113-1117.
11. Conilleau V, Dompmartin A, Verneuil L, Michel M, Leroy D. Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis. 1999;41:141-144.
12. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001;137:301-304.
13. Aihara M, Sugita Y, Nagatani T, et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol. 2001;144:1231-1234.
14. Fujino Y, Nakajima M, Inoue H, et al. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol. 2002;51:771-774.
15. Descamps V, Collot S, Houhou N, Ranger-Rogez S. Human herpesvirus-6 encephalitis associated with hypersensitivity syndrome. Ann Neurol. 2003;53:280.
16. Kunisaki Y, Goto H, Kitagawa K, Nagano M. Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6. Intern Med. 2003;42:203-207.
17. Masaki T, Fukunaga A, Tohyama M, et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol. 2003;83:128-131.
18. Descamps V, Mahe E, Houhou N, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol. 2003;148:1032-1034.
19. Aihara Y, Ito SI, Kobayashi Y, et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol. 2003;149:165-169.
20. Descamps V, Collot S, Mahe E, et al. Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. J Invest Dermatol. 2003;121:215-216.
21. Zeller A, Schaub N, Steffen I, et al. Drug hypersensitivity syndrome to carbamazepine and human herpes virus 6 infection: case report and literature review. Infection. 2003;31:254-256.
22. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004;140:183-188.
23. Levy JA. Three new human herpesviruses (HHV6, 7, and 8). Lancet. 1997;349:558-562.
24. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthema subitum. Lancet. 1988;1:1065-1067.
25. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus infection in young children. N Engl J Med. 1992;326:1445-1452.
26. Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol. 1989;27:651-653.
27. Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence to the virus in the population. Lancet. 1990;335:1047-1050.
28. Niederman JC, Liu C-R, Kaplan MH, Brown NA. Clinical and serological features of human herpesvirus-6 infection in 3 adults. Lancet. 1988;2:817-819.
29. Steeper TA, Horowitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol. 1990;93:776-783.
30. Akashi K, Eizuru Y, Sumiyoshi Y, et al. Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med. 1993;329:168-171.
31. Morris DJ, Littler E, Arrand JR, et al. Human herpesvirus 6 infection in renal transplant recipients. N Engl J Med. 1989;320:1560-1561.
32. Sutherland S, Christofinis G, O'Grady J, et al. A serological investigation of human herpesvirus 6 infections in liver transplant recipients and the detection of cross-reacting antibodies to cytomegalovirus. J Med Virol. 1991;33:172-176.
33. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood. 1991;78:1381-1384.
34. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med. 1996;124:1065-1071.
35. Appleton AL, Sviland L, Peiris JS, et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Bone Marrow Transplant. 1995;16:777-782.
36. Sola P, Merelli E, Mascara R, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry. 1993; 56:917-919.
37. Ruzicka T, Kalka K, Diercks K, et al. Papular-purpuric "gloves and socks" syndrome associated with human herpesvirus 6 infection. Arch Dermatol. 1998; 134:242-244.
38. Yadav M, Chandrashekran A, Vasudevan DM, Ablashi DV. Frequent detection of human herpes virus 6 in oral carcinoma. J Natl Cancer Inst. 1994;86:1792-1794.
39. Leach CT, Newton ER, McParlin S, Jenson HB. Human herpesvirus 6 infection of the female genital tract. J Infect Dis. 1994;169:1281-1283.
40. Torelli G, Marasca R, Luppi M, et al. Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood. 1991;77:2251-2258.
41. Desachy A, Ranger-Rogez S, Francois B, et al. Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis. 2001;32:197-203.
42. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J Infect Dis. 2002;185:110-113.
43. Frenkel N, Schirmer EC, Katsafanas G, June CH. T-cell activation is required for efficient replication of human herpesvirus 6. J Virol. 1990;64:4598-4602.
44. Mauri-Hellweg D, Bettens F, Mauri D, et al. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol. 1995;155:462-472.
45. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr Dpin Allergy Clin Immunol. 2003;3:255-260.
46. Aarli A. Immunoglobulins in epilepsy. Springer Semin Immunopathol. 1985;8:5-27.
47. Sorrell TC, Forbes IJ, Burness FR, et al. Depression of immunologic function in patients treated with phenytoin sodium. Lancet. 1971;2:1233-1235.
48. Grob GJ, Herold GE. Immunologic abnormalities and hydantoins. BMJ. 1972;2:561-563.
49. Pereira LF, Sanchez JF. Reversible panhypogammaglobulinaemia associated with phenytoin treatment. Scand J Infect Dis. 2002;34:785-787.
50. Britigan BE. Diphenylhydantoin-induced hypogammaglobulinemia in a patient infected with human immunodeficiency virus. Am J Med. 1991;90:524-527.
51. Travin M, Macris NT, Block JM, Schwimmer D. Reversible common variable immunodeficiency syndrome induced by phenytoin. Arch Intern Med. 1989;149:1421-1422.
52. Guerra IC, Fawcett WA, Redmon AH, et al. Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity. J Allergy Clin Immunol. 1986; 77:603-608.
53. Lillie MA, Yang LC, Honig PJ, August CS. Erythroderma, hypogammaglobulinemia, and T-cell lymphocytosis: occurrence following therapy with phenytoin. Arch Dermatol. 1983;119:415-418.
54. Dosch HM, Jason J, Gelfand EW. Transient antibody deficiency and abnormal T-suppressor cells induced by phenytoin. N Engl J Med. 1982;306:406-409.
55. De Gast GC, The TH, Viersma JW, et al. Reversible hypogammaglobulinaemia after diphenylhydantoin and hydroxyzine therapy. Neth J Med. 1974;17:261-269.
56. van Ginneken EEM, van der Meer JWM, Netten PM. A man with a mysterious hypogammaglobulinaemia and skin rash. Neth J Med. 1999;54:158-162.
57. Spickett GP, Gompels MM, Saunders PWG. Hypogammaglobulinemia with absent B lymphocytes and agranulocytosis after carbamazepine treatment. J Neurol Neurosurg Psychiatry. 1996;60:459.
58. Garcia Rodriguez MC, de la Concha EG, Fontan G, et al. Transient hypogammaglobulinemia in the adult: functional assessment of T and B lymphocytes. J Clin Lab Immunol. 1983;11:55-58.
59. Knutsen AP, Anderson J, Satayaviboon S, Slavin RG. Immunologic aspects of phenobarbital hypersensitivity. J Pediatr. 1984;105:558.
60. Joubert PH, Aucamp AK, Potgieter GM, Verster F. Epilepsy and IgA deficiency: the effect of sodium valproate. S Afr Med J. 1977;52:642-644.
61. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis. 1995;171:273-280.
62. Gopal MR, Thomson BJ, Fox J, et al. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet. 1990; 335:1598-1599.
63. Jarrett RF, Clark DA, Josephs SF, Onions DE. Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol. 1990;32:73-76.
64. Dockrell DH, Smith TF, Paya CV. Human herpesvirus 6. Mayo Clin Proc. 1999; 74:163-170.